Our results suggest that tumor-infiltrating CD8+ TEX may therefore inadvertently yield a rich source of IFN-γ in the TME that is protumorigenic and prometastatic in the context of ER+ BC tumors. The gene discussed is ESR1; the disease is breast cancer.